Evidence map›Paper›PMID 32796024›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2020

Diversity Outbred Mice Reveal the Quantitative Trait Locus and Regulatory Cells of HER2 Immunity.

Wei-Zen Wei, Heather M Gibson, Jennifer B Jacob, Jeffrey A Frelinger, Jay A Berzofsky, Hoyoung Maeng, Gregory Dyson, Joyce D Reyes, Shari Pilon-Thomas, Stuart Ratner and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Fifteen years of the Diversity Outbred mouse model: a review.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
  2. Breast Cancer Immunity: It is TIME for the Next Chapter.Cold Spring Harbor perspectives in medicine · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Wei-Zen WeiDepartment of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201; weiw@karmanos.org.ORCID 0000-0001-6036-3610
Heather M GibsonDepartment of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201.ORCID 0000-0003-2652-8252
Jennifer B JacobDepartment of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201.ORCID 0000-0002-3173-2496
Jeffrey A FrelingerValley Fever Center of Excellence, Department of Immunobiology, University of Arizona, Tucson, AZ 85724.
Jay A BerzofskyVaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892; and.ORCID 0000-0002-0342-3194
Hoyoung MaengVaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892; and.ORCID 0000-0002-8194-6089
Gregory DysonDepartment of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201.
Joyce D ReyesDepartment of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201.
Shari Pilon-ThomasDepartment of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612.
Stuart RatnerDepartment of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201.ORCID 0000-0002-1647-4572
Kuang-Chung WeiDepartment of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201.
Wayne State University · USNational Cancer Institute · USMoffitt Cancer Center · USUniversity of Arizona · US

Funding

DEVELOPMENT OF ERBB2 BASED BREAST CANCER VACCINESR01CA076340 · NCI · WAYNE STATE UNIVERSITY · PI WEI, WEI-ZEN · 1998 to 2020
$5.2M
NCI NIH HHS R01 CA076340
6 · The paper itself

Abstract

The genetic basis and mechanisms of disparate antitumor immune response was investigated in Diversity Outbred (DO) F1 mice that express human HER2. DO mouse stock samples nearly the entire genetic repertoire of the species. We crossed DO mice with syngeneic HER2 transgenic mice to study the genetics of an anti-self HER2 response in a healthy outbred population. Anti-HER2 IgG was induced by Ad/E2TM or naked pE2TM, both encoding HER2 extracellular and transmembrane domains. The response of DO F1 HER2 transgenic mice was remarkably variable. Still, immune sera inhibited HER2+ SKBR3 cell survival in a dose-dependent fashion. Using DO quantitative trait locus (QTL) analysis, we mapped the QTL that influences both total IgG and IgG2(a/b/c) Ab response to either Ad/E2TM or pE2TM. QTL from these four datasets identified a region in chromosome 17 that was responsible for regulating the response. A/J and NOD segments of genes in this region drove elevated HER2 Ig levels. This region is rich in MHC-IB genes, several of which interact with inhibitory receptors of NK cells. (B6xA/J)F1 and (B6xNOD)F1 HER2 transgenic mice received Ad/E2TM after NK cell depletion, and they produced less HER2 IgG, demonstrating positive regulatory function of NK cells. Depletion of regulatory T cells enhanced response. Using DO QTL analysis, we show that MHC-IB reactive NK cells exert positive influence on the immunity, countering negative regulation by regulatory T cells. This new, to our knowledge, DO F1 platform is a powerful tool for revealing novel immune regulatory mechanisms and for testing new interventional strategies.

Indexed as

AnimalsAnimals, Outbred StrainsAutoantigensErb-b2 Receptor Tyrosine KinasesFemaleHistocompatibility Antigens Class IIHumansImmunityImmunoglobulin GIsoantigensKiller Cells, NaturalMiceMice, Inbred BALB CMice, Inbred C57BLMice, TransgenicProtein DomainsAutoantigensERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesHistocompatibility Antigens Class IIImmunoglobulin GIsoantigens

Identifiers

PMID32796024
PMCPMC7484363
OpenAlexW3048524951

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.